The entry of adalimumab biosimilars in Europe: an overview of price evolution and country responses

Evelien Moorkens, Brian Godman, Isabelle Huys, Arnold G. Vulto

Research output: Contribution to conferencePosterpeer-review

32 Downloads (Pure)

Fingerprint

Dive into the research topics of 'The entry of adalimumab biosimilars in Europe: an overview of price evolution and country responses'. Together they form a unique fingerprint.

Immunology and Microbiology

Economics, Econometrics and Finance